Agoracom Blog Home

Posts Tagged ‘Nutraceuticals’

Primo Nutraceuticals Inc. $PRMO.ca and Dan Duquette Former MLB Executive Enter into Letter of Intent for the Development of a Global Supply of #PPE products & Primo Hand Sanitizer

Posted by AGORACOM-JC at 8:50 AM on Tuesday, September 1st, 2020
  • Entered into a Letter of Intent with Duquette Consulting LLC (the “LOI”), a company owned by Dan Duquette.
  • Dan Duquette is a twice named Major League Baseball (MLB) Executive of the Year and former Executive Vice-President of the Baltimore Orioles, General Manager of the Montreal Expos, Boston Red Sox, and Milwaukee Brewers
  • Dan Duquette has joined forces with Primo Nutraceuticals to partner in the development, sourcing and the global supply of personal protective equipment products including Primo’s hand sanitizer

VANCOUVER, British Columbia, Sept. 01, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce it has entered into a Letter of Intent with Duquette Consulting LLC (the “LOI”), a company owned by Dan Duquette. Dan Duquette is a twice named Major League Baseball (MLB) Executive of the Year and former Executive Vice-President of the Baltimore Orioles, General Manager of the Montreal Expos, Boston Red Sox, and Milwaukee Brewers (https://en.wikipedia.org/wiki/Dan_Duquette). Dan Duquette has joined forces with Primo Nutraceuticals to partner in the development, sourcing and the global supply of personal protective equipment (“PPE”) products including Primo’s hand sanitizer.

In June 2020 Primo received its first shipment of its lemon hand sanitizer and immediately began sending out samples to procurement departments, receiving positive feedback regarding the quality of the product. Duquette Consulting & their affiliates will help Primo in marketing the hand sanitizer via their partnership channels, marketing brochures & e-commerce sites exposing the Company’s products on a global scale. As Primo is expanding into the Canadian market the Company must have an MDEL (Medical Device Establishment License) to comply with the regulations of Health Canada relating to companies seeking to sell, distribute, manufacture or import medical equipment in Canada. Primo and Duquette Consulting will work towards securing the necessary licenses required to sell nitrile gloves, N95 surgical masks & KN95 masks and gowns. The Company is extremely focused on developing the right partnerships that will encourage the Company’s growth into the market sector of health and wellness. Primo is extremely optimistic that building these strategic types of relationships will prove fruitful for the Company and its shareholders in the very near future.

Duquette Consulting entered the PPE market by sourcing and selling products and supplies at a government & state level to help in the fight against COVID-19, securing, shipping and recently delivering over 5 million masks to the State of Maryland in the United States (the “U.S”). Duquette Consulting partnered with Crowley Worldwide (www.crowley.com) a large logistics conglomerate with over USD $2 billion in annual revenue, offering services to the U.S. Department of Defense, the Department of Homeland Security and other state and federal agencies in the U.S.; top medical equipment suppliers, with financial backing by Citibank. A Duquette Consulting press release is located at the following link: https://dcppe.net/case-study/

The strategic partnership contemplated in the LOI is extremely beneficial for Primo, opening the doors to potential massive orders for the Company’s hand sanitizer worldwide. With the recent issuance of a Government Procurement number to Primo by the Canada Revenue Agency and the LOI with Duquette Consulting LLC, Primo could soon be able to bid on government tenders not only for hand sanitizer, but for N95 surgical masks, KN95 masks, nitrile surgical gloves and gowns. All PPE products would meet the certification standards of the market place including the FDA, CDC, MOD and NIOSH approval requirements.

Richard Cindric, CEO of Primo comments:“We are excited to partner with Mr. Duquette. Together we will provide our line of hand sanitizer to Dan’s already established PPE supply chain processes and distribution network of companies across the U.S.A. and abroad.”

Andy Jagpal, President of Primo comments: “We are extremely pleased to partner with Mr. Duquette to develop a global supply chain of personal protection equipment. We look forward to working with Dan and his team.”

Dan Duquette, CEO Duquette Consulting LLC comments: “Our new partnership with Primo contemplated in the LOI will afford Duquette Consulting the opportunity to broaden our offerings to those in need of PPE.  Our recent success in supplying the State of Maryland with over five millions NIOSH approved Surgical Masks is a prime example of our ability to meet the need of institutional buyers who are looking for both quality products from a reputable firm who can deliver in an expedient and cost effective manner. As well as adding in our ability to finance our transactions is a significant differentiator that separates us in the PPE marketplace.”

Joel DeBellefeuille, Director of Primo comments: ”I’ve known Dan for a few years now and I couldn’t be happier to continue working and collaborating with him on amazing deals and partnerships. This is a major plus for Primo and its shareholders. Dan is an extremely influential person with a network of people spanning the globe.”

About Dan Duquette

Dan Duquette is a MLB veteran (Major League Baseball) Executive whose leadership built winning teams and enterprise value of club and media assets over an 18 year career. Successfully executing plans to immediately turn around the Montreal Expos, Boston Red Sox and Baltimore Orioles as entertaining teams to grow fan base, improve revenues, expand market share and improve content distribution. He is also the founder of the Dan Duquette Sports Academy. He has twice been named the Major League Baseball Executive of the Year by Sporting News in 1992 with the Expos and in 2014 with the Baltimore Orioles.

About Duquette Consulting LLC

Duquette Consulting is a management consulting company. With the advent of the worldwide pandemic, we have focused our efforts to help combat the effects of COVID19. In doing so, we established a network of international companies and entities who specialize in supporting the emergency management community in times of crisis. As part of our covid-19 initiative, Duquette Consulting manages and coordinates the procurement and acquisition for both the public and private sectors, domestically and internationally of Personal Protection Equipment (PPE). Our partnership has banking relationships that allow Duquette Consulting’s Partnership group the ability to finance large scale supply of PPE items such as masks, gloves and gowns. Our products are of the highest quality and meet the certifications standards of the marketplace including the FDA, CDC, MOD, and NIOSH approval requirements.

About Primo Nutraceuticals

Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

Andy Jagpal

Andy Jagpal
President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected].

To learn more about what this news means to the shareholders visit:

www.primonutraceuticals.com
www.twitter.com/Prmoinc
www.thrivecbd.com
www.mariannacorp.com
www.dcppe.net

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.

Primo Nutraceuticals Inc.,$PRMO.ca and World Agri Minerals Ltd. Discuss Potential Development of a Proprietary Natural Mineral Blend to Increase Production for Mushroom Growers $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 8:24 AM on Friday, June 5th, 2020
  • Announced that further to its letter of intent with World Agri-Minerals Ltd. , announced in the Company’s news release dated June 4, 2020, Primo and WAM have conducted discussions relating to the development and production of a proprietary mineral blend specially designed for employment by psilocybin mushroom growers
  • Company has identified growing global interest in the potential medical applications of psilocybin and other psychedelic mushrooms
  • WAM claims that their current research and testing will result in benefits similar to those attained when using their already successful GENESIS 89 GOLD blend on Hemp and Cannabis production.

VANCOUVER, British Columbia, June 05, 2020 – PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that further to its letter of intent (“LOI”) with World Agri-Minerals Ltd. (“WAM”), announced in the Company’s news release dated June 4, 2020, Primo and WAM have conducted discussions relating to the development and production of a proprietary mineral blend specially designed for employment by psilocybin mushroom growers.

The Company has identified growing global interest in the potential medical applications of psilocybin and other psychedelic mushrooms. With world-wide interest in this burgeoning Agri-landscape, WAM is currently developing a new proprietary mineral blend focused on enhancing the production and quality of mushrooms and in particular psychedelic mushroom production. WAM claims that their current research and testing will result in benefits similar to those attained when using their already successful GENESIS 89 GOLD blend on Hemp and Cannabis production. With the new WAM proprietary mineral natural mushroom blend, a healthy more vibrant and 100% organic product can be grown more economically thereby allowing product cost savings for the consumers in addition to enabling growers to be more efficient and profitable. WAM claims that that GENESIS 89 GOLD can increase Hemp and Cannabis productivity anywhere from 15% to 35%. WAM believes that a new mushroom blend could provide similar if not greater production numbers for psilocybin and other mushroom varieties grown for medical applications.

The Mushroom Market

According to the Psychedelic Science Review, the global market for conventional anti-depressants was valued at $13.7 billion in 2016 and is projected to grow to $15.9 billion by 2023.

Andy Jagpal, President Comments:

“We believe that Primo is especially well positioned to capitalize on the emerging ‘shroom boom’ Psilobycin and other varieties of mushrooms are quickly becoming a viable option for mental and physical health treatment. The market for investment opportunity is massive for a nutraceutical company like Primo which has demonstrated its ability to receive NPNs (Natural Product Number) from the Health Products and Food Branch of Health Canada for nutraceutical products.”

About World Agri Minerals Ltd. (WAM)

WAM was formed to actively pursue the manufacturing, marketing and sales of its premiere commercial Agri-product GENESIS 89, an organic plant nutrient that has a proven positive effect on agri-production. WAM now plans to use this same unique blending process to change the way the mushroom industry grows and fertilizes their product. With over 80 trace minerals, GENESIS 89 and GENESIS 89 GOLD contains a proprietary blend that boasts the highest concentration of seawater-harvested minerals available on the commercial and retail market.

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoid (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

Shop: www.primoceuticals.com

www.twitter.com/prmonutra

https://t.me/PrimoNutraceuticals

www.thrivecbd.org

www.beautykitchen.net

www.drinkdefy.com

www.worldagriminerals.com

Corporate: www.primonutraceuticals.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

Primo Nutraceuticals Inc. $PRMO.ca Signs Letter of Intent to Enter into Funding and Asset Purchase Agreement with World Agri Minerals Ltd. $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:13 AM on Wednesday, June 3rd, 2020
  • Announced that it has signed a non-binding letter of intent to provide funding and to acquire up to 100% of the assets and inventory of World Agri Minerals Ltd.
  • WAM is engaged in the research and development of enhanced production methods using organic plant nutrients and trace minerals found in its GENESIS 89 and GENESIS 89 GOLD product line
  • Products are completed and ready for sales and distribution to growers as a concentrate
  • Product interest has been global

VANCOUVER, British Columbia, June 03, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has signed a non-binding letter of intent (“LOI”) to provide funding and to acquire up to 100% of the assets and inventory of World Agri Minerals Ltd. (“WAM”), together (the “Parties”). WAM is engaged in the research and development of enhanced production methods using organic plant nutrients and trace minerals found in its GENESIS 89 and GENESIS 89 GOLD product line.

WAM was formed to actively pursue the manufacturing, marketing and sales of its premiere commercial agri-product GENESIS 89, an organic plant nutrient that has a proven positive effect on agri-production. WAM now plans to use this same unique blending process to change the way the mushroom industry grows and fertilizes their product. With over 80 trace minerals, GENESIS 89 contains a proprietary blend that boasts the highest concentration of seawater-harvested minerals available on the commercial and retail market.

Current products “GENESIS 89” and “GENESIS 89 GOLD” are completed and ready for sales and distribution to growers as a concentrate. Product interest has been global. As well, several new products are in the research and development phase, not the least of which is a unique blend of trace minerals, similar to that of GENESIS 89 GOLD, designed specifically for the psychedelic mushroom marketplace. WAM is positioned with upward trending organic agri-farming, as well as the medical and recreational hemp/cannabis and psychedelic mushroom industries.

The Parties intend to draft and execute a definitive agreement (the “Definitive Agreement”) with detailed terms as soon as practicable, and complete the transaction on or before June 20, 2020. Terms of the LOI are subject to change as set out in the Definitive Agreement. The final valuation will be determined by an independent third-party evaluator, which is currently in progress.

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoid (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

Shop: www.primoceuticals.com

www.twitter.com/prmonutra

https://t.me/PrimoNutraceuticals

www.thrivecbd.org

www.beautykitchen.net

www.drinkdefy.com

www.worldagriminerals.com

Corporate: www.primonutraceuticals.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/77b24a04-64f8-4f81-93b8-737e3a6dbc82

agri-product GENESIS 89
an organic plant nutrient that has a proven positive effect on agri-production

Source: GlobeNewswire (June 3, 2020 – 9:00 AM EDT)

News by QuoteMedia
www.quotemedia.com

Primo Nutraceuticals Inc. $PRMO.ca Receives Approval to Sell its Hand Sanitizer on #Amazon.com $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:20 AM on Tuesday, June 2nd, 2020
  • Announced that it has received approval from Amazon to sell their Primo Lemon Hand Sanitizer in Amazon’s Personal Safety & Household category
  • Through continued perseverance and multiple discussions with customer care, and due to Primo meeting all the required criteria as a licensed establishment with a product that has been licensed and approved by Health Canada, Primo was finally granted permission from Amazon to sell its hand sanitizer on their website.

VANCOUVER, British Columbia, June 02, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has received approval from Amazon to sell their Primo Lemon Hand Sanitizer in Amazon’s Personal Safety & Household category.

In response to the increasing demand for hand sanitizers in Canada, approximately two months ago Primo filled out an online application to sell its hand sanitizer on Amazon. Primo was granted a Seller Central account but was initially denied the ability to list its hand sanitizer, as Amazon was no longer approving new listings in this category. In early March, Amazon began restricting the types of sellers on its third-party Marketplace platform that are able to sell health and sanitation products, such as: face masks, hand sanitizer, disinfecting wipes/ sprays, isopropyl alcohol, among other products. 

Through continued perseverance and multiple discussions with customer care, and due to Primo meeting all the required criteria as a licensed establishment with a product that has been licensed and approved by Health Canada, Primo was finally granted permission from Amazon to sell its hand sanitizer on their website.

The approval by Amazon could not have come at a better time for the company as its first shipment of hand sanitizer was picked up at their manufacturer on Friday, May 29th, 2020 with an expected delivery of later this week.

In reference to the company’s press release dated March 24th, Primo will be handing out the hand sanitizer as well as promotional samples for procurement departments in the healthcare industry across Canada to essential workers.

The company will also be taking the opportunity to hand out samples to potential customers that are interested in purchasing the hand sanitizer in bulk orders.

To view the product brochure, please visit: https://www.primoceuticals.com/shop#!/Primo-Lemon-Hand-Sanitizer-60/p/197662415/category=0

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC. 

“Andy Jagpal” 

President and Director 

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected] 

To learn more about what this news means to the shareholders visit: 

Shop: www.primoceuticals.com 

www.twitter.com/prmonutra 

https://t.me/PrimoNutraceuticals

www.thrivecbd.org 

www.beautykitchen.net 

www.drinkdefy.com 

Corporate: www.primonutraceuticals.com 

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

Primo Nutraceuticals $PRMO.ca Receives NPN (Natural Product Number) from Health Canada $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 4:42 PM on Friday, May 22nd, 2020

– Received its NPN (Natural Product Number) from Health Canada.

– Primo Nutraceuticals hand sanitizers meet Health Canada’s requirements for safety, effectiveness and quality.

– In response to the increasing demand for hand sanitizers in Canada during the current COVID-19 pandemic, Health Canada has implemented an interim expedited licensing approach to help businesses like Primo to obtain the required authorizations to produce and distribute hand sanitizer.

VANCOUVER, British Columbia, May 22, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has received its NPN (Natural Product Number) from Health Canada. Primo Nutraceuticals hand sanitizers meet Health Canada’s requirements for safety, effectiveness and quality.

In response to the increasing demand for hand sanitizers in Canada during the current COVID-19 pandemic, Health Canada has implemented an interim expedited licensing approach to help businesses like Primo to obtain the required authorizations to produce and distribute hand sanitizer. Consistent with the interim measure for alcohol-based hand sanitizers currently in place, Primo’s hand sanitizer can be distributed to healthcare and commercial settings across Canada.

The Natural Product Number NPN 80099466 issued to Primo will be located on every Primo product label distributed.

The Natural Product Number contains information about the natural health product and found to be safe, effective and of high quality under their recommended conditions of use. You can identify licensed natural health products by looking for the eight-digit Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM) on the label.

Sales are to commence in June 2020. No purchase orders are yet in place.

To view the product brochure visit: https://www.primoceuticals.com/shop#!/Primo-Lemon-Hand-Sanitizer-60/p/197662415/category=0

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

https://t.me/PrimoNutraceuticals

Shop: www.primoceuticals.com

www.twitter.com/prmonutra

www.thrivecbd.org

www.beautykitchen.net

www.marianna.ca

www.drinkdefy.com

Corporate: www.primonutraceuticals.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c8349cf6-4f9e-49b2-9769-53f0c3274f0d

Primo Hand Sanitizer
Primo Nutraceuticals hand sanitizers meet Health Canada’s requirements for safety, effectiveness and quality.

Primo Nutraceuticals Inc. $PRMO.ca Receives Site License from Health Canada $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:22 AM on Friday, May 15th, 2020
  • Received the ability to import Hand Sanitizer for the duration of the COVID-19 emergency response from the Health Products and Food Branch of Health Canada
  • Site License Number: COV0950 was issued by the Natural and Non-prescription Health Products Directorate of Health Canada

VANCOUVER, British Columbia, May 15, 2020  — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has received the ability to import Hand Sanitizer for the duration of the COVID-19 emergency response from the Health Products and Food Branch of Health Canada.

“This license specifically authorizes the license-holder to manufacture, package, label and/or import “antiseptic Skin Cleansers/Hand Sanitizers” as described in the Product Monograph provided by Primo Nutraceuticals Inc., to Health Canada. The following site is considered to-be-in compliance with GMP requirements outlined in PART 3 of the Natural Health Products Regulations. Activities include: Importing to Canada and Manufacturing, Packaging and Labeling from the U.S.A.”

Site License Number: COV0950 was issued by the Natural and Non-prescription Health Products Directorate of Health Canada to Primo Nutraceuticals Inc. (CSE:PRMO) on April 21st, 2020.

Further to the press release dated March 24, 2020, where Primo signed a production order with Celebrity Driven Brand Beauty Kitchen to provide 1,000 units of free non-hydroalcoholic hand sanitizer. The hand sanitizer will be produced by beauty kitchen, located at 1512 Industrial Rd. Boulder City, Nevada. The production Facility currently has the capacity to produce $450,000USD of product per month. The relationship with Beauty Kitchen has allowed Primo to private label most of Beauty Kitchens product line. This allows Primo to produce product without the construction of its own facility.

The initial run of 1,000 units was financed internally. Future production orders will be financed as procurement orders from the health industry are received. The company will entertain options for equity financing once orders start to come in. The sample of 1,000 units will be handed out to hospital and health care industry professionals.

The management team and Board of Directors at Primo have decided that after handing out all 1,000 units, the hand sanitizer will be made available for purchase directly from the Company’s online shop at:www.primoceuticals.com/shop Users of the site may also notice that the Company has recently added to the shop a ready to purchase Primo branded, breathable, washable and re-usable neck gaiter/face mask that can be used in assisting to combat the virus.

Andy Jagpal, President Comments

“This is an absolute win for the company. We have joined companies like Purell who have been permitted to provide these essential products to combat the spread of the Corona virus. Our goal is to be able to bid on procurement contracts from government hospitals and nursing home facilities as soon as our 1,000 sample hand sanitizer arrive.”

“I would also like to add, if you’re a private corporation, healthcare center, pharmacy or any type of business that requires hand sanitizer to fight against the virus, we ask that you send your requests to Primo at: [email protected] so that we can fulfill those orders without delay.”

About Primo Nutraceuticals

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

Shop:www.primoceuticals.com

www.twitter.com/prmonutra

www.thrivecbd.org

www.beautykitchen.net

www.drinkdefy.com

Corporate:www.primonutraceuticals.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.No regulatory authority has approved or disapproved the information contained in this news release.UnfollowRecommend

PRIMO Nutraceuticals $PRMO.ca – #CBD Nutraceuticals Market Demand, Supply, Growth Factors, Latest Rising Trend & Forecast to 2027 $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 12:53 PM on Tuesday, May 5th, 2020

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

CBD Nutraceuticals Market Demand, Supply, Growth Factors, Latest Rising Trend & Forecast to 2027

The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries including Life Science, and many more. Trade barriers are further restraining the demand- supply outlook.

As government of different regions have already announced total lockdown and temporarily shutdown of industries, the overall production process being adversely affected; thus, hinder the overall CBD Nutraceuticals Market globally. This report on ‘CBD Nutraceuticals Market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The report also showcase market trends and forecast to 2027, factoring the impact of Covid -19 Situation.

A nutraceutical is a pharmaceutical alternative that claims physiological benefits. Nutraceutical product is a food or fortified food product that not only supplements the diet but also assists in treating or preventing disease (apart from anemia), so it provides medical benefits. A naturally-occurring compound found in plants, cannabidiol (CBD), belongs to a family of compounds called cannabinoids. Examples of nutraceuticals are natural foods, including antioxidants, dietary supplements, fortified dairy products, and citrus fruits, and vitamins, minerals, herbals, milk, and cereals.

The CBD nutraceuticals market is anticipated to grow due to the products as they are more convenient and travel-friendly. However, the presence of alternatives like the herbal nutraceuticals, such as echinacea, and turmeric that have ruled the global nutraceuticals space for a long period, is restraining the market growth. Moreover, the growing demand for hemp protein among athletes, bodybuilders, and the vegan population is expected to drive the market for cannabidiol (CBD) nutraceuticals over the forecast period.

Key Players Influencing the Market:

1. Bluebird Botanicals
2. CV Sciences, Inc.
3. Elixinol LLC
4. Endoca BV
5. Foria Wellness
6. Garden of Life
7. Green Roads
8. Isodiol
9. Medical Marijuana, Inc.
10. MEDTERRA

Market Segmentation:

The CBD nutraceuticals market is segmented on the basis of product type, and sales channel. Based on product type the market is segmented as CBD tinctures, capsules & softgels, CBD gummies, others. On the basis of sales channel the market is categorized as retail stores and online pharmacies.

Source: https://coleofduty.com/news/2020/05/05/cbd-nutraceuticals-market-demand-supply-growth-factors-latest-rising-trend-forecast-to-2027/